C21 steroid-enriched fraction refined from Marsdenia tenacissima inhibits hepatocellular carcinoma through the coordination of Hippo-Yap and PTEN-PI3K/AKT signaling pathways.
C21 steroid-enriched fraction refined from Marsdenia tenacissima inhibits hepatocellular carcinoma through the coordination of Hippo-Yap and PTEN-PI3K/AKT signaling pathways.
复制标题
从 Marsdenia tenacissima 中精制的富含 C21 类固醇的组分通过协调 Hippo-Yap 和 PTEN-PI3K/AKT 信号通路抑制肝细胞癌
DOI:
10.18632/oncotarget.22833
复制
发表时间:
2017-12-15
期刊:
影响因子:
--
通讯作者:
Wang Z
中科院分区:
文献类型:
--
作者:
Zhang Y;Li K;Ying Y;Chen B;Hao K;Chen B;Zheng Y;Lyu J;Tong X;Chen X;Wang Y;Zhan Z;Zhang W;Wang Z
Marsdenia tenacissimae extraction (MTE), a traditional herbal medicine, has exhibited anti-tumor effects on a variety of cancers. However, its effectiveness and the mechanism of action in Hepatocellular carcinoma (HCC) has not been fully understood. In the present study, we demonstrate that C21 steroid-enriched fraction from MTE, which contains five main C21 steroids (FR5) exhibits obvious pharmacological activities on HCC cells in vitro and in vivo. FR5 induces apoptosis and inhibits proliferation and migration of HepG2 and Bel7402 cells in a dose and time dependent manner. Furthermore, in HCC cells, we found that FR5 inhibits Hippo pathway, leading to inactivation of YAP and increase of PTEN. Enhanced PTEN results in the inhibition of PI3K/AKT signaling pathway, inhibiting cell proliferation by FR5 and FR5-induced apoptosis. Moreover, it was proved that FR5 treatment could inhibit tumor growth in a HCC xenograft mouse model, and immunohistochemistry results showed FR5 treatment resulted in down-regulation of Bcl-2 and YAP, and up-regulation of PTEN and PI3K. Taken together, we found that FR5 effectively inhibits proliferation and induces apoptosis of HCC cells through coordinated inhibition of YAP in the Hippo pathway and AKT in the PI3K-PTEN-mTOR pathway, and suggest FR5 as a potential therapy for HCC.
登录
查看更多内容
影响因子:
16
作者:
Bhola PD;Letai A
通讯作者:
Letai A
影响因子:
--
作者:
Lynch JT;McEwen R;Crafter C;McDermott U;Garnett MJ;Barry ST;Davies BR
通讯作者:
Davies BR
影响因子:
4.6
作者:
Li YH;Fu HL;Tian ML;Wang YQ;Chen W;Cai LL;Zhou XH;Yuan HB
通讯作者:
Yuan HB
影响因子:
13.5
作者:
Roayaie, Sasan;Obeidat, Khaled;Sposito, Carlo;Mariani, Luigi;Bhoori, Sherrie;Pellegrinelli, Alessandro;Labow, Daniel;Llovet, Josep M.;Schwartz, Myron;Mazzaferro, Vincenzo
通讯作者:
Mazzaferro, Vincenzo
影响因子:
3.1
作者:
Erasalo, Heikki;Laavola, Mirka;Moilanen, Eeva
通讯作者:
Moilanen, Eeva